GTCM
XENT

Gyon Technologies Capital Management’s Intersect ENT, Inc XENT Stock Holding History

Gyon Technologies Capital Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13,318
Closed -$278K – 525
2021
Q1 		$278K Sell
13,318
-19,298
-59% -$445K 0.12% 296
2020
Q4 		$747K Buy
+32,616
New +$621K 0.26% 120

Other funds holding XENT

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Gyon Technologies Capital Management's XENT Position: Q2 2021 in Review

Gyon Technologies Capital Management sold out of Intersect ENT, Inc (XENT) in Q2 2021, closing a stake of 13,318 shares — an estimated $278K sold.

Gyon Technologies Capital Management first reported a position in XENT in Q4 2020 and held it in 2 quarters. The position peaked at $747K in Q4 2020. 107 funds tracked by Wall St. Rank hold XENT as of Q2 2021.

  • Gyon Technologies Capital Management reported no remaining Intersect ENT, Inc position as of Q2 2021 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 13,318 Intersect ENT, Inc shares in Q2 2021, an estimated $278K.
  • Gyon Technologies Capital Management first reported a position in Intersect ENT, Inc in Q4 2020 and held it in 2 quarters.
  • Gyon Technologies Capital Management's Intersect ENT, Inc position peaked at $747K in Q4 2020.
  • 107 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2021.

Based on Gyon Technologies Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.